Cytosorbents Corporation (CTSO)’s Wedge Up Points to Lower Stock Risks

March 20, 2018 - By Michael Collier

Investors sentiment increased to 1.27 in Q3 2017. Its up 0.54, from 0.73 in 2017Q2. It is positive, as 8 investors sold Cytosorbents Corporation shares while 3 reduced holdings. 6 funds opened positions while 8 raised stakes. 2.38 million shares or 26.98% more from 1.87 million shares in 2017Q2 were reported.
Thompson Davis & Company holds 0.01% or 1,000 shares. Morgan Stanley reported 6,862 shares. Geode Capital Ltd Llc reported 127,125 shares stake. Manatuck Hill Ptnrs Ltd Liability Co reported 150,000 shares stake. Fortaleza Asset Management Inc reported 0.27% in Cytosorbents Corporation (NASDAQ:CTSO). Peak6 Limited Partnership holds 0% or 74,622 shares in its portfolio. Raymond James & reported 0% in Cytosorbents Corporation (NASDAQ:CTSO). Pnc Svcs Gp Inc holds 0% or 20,000 shares in its portfolio. Salem Investment Counselors Incorporated owns 0.01% invested in Cytosorbents Corporation (NASDAQ:CTSO) for 13,000 shares. Skylands Cap Llc invested 0.41% in Cytosorbents Corporation (NASDAQ:CTSO). Vanguard Gp Inc accumulated 0% or 799,932 shares. State Street Corporation, a Massachusetts-based fund reported 12,000 shares. Moreover, California Employees Retirement Systems has 0% invested in Cytosorbents Corporation (NASDAQ:CTSO). Financial Bank Of Mellon accumulated 25,519 shares. Millennium Lc holds 41,217 shares or 0% of its portfolio.

Since January 8, 2018, it had 0 insider purchases, and 4 insider sales for $433,810 activity.

The stock of Cytosorbents Corporation (CTSO) formed an up wedge with $7.83 target or 3.00 % above today’s $7.61 share price. The 8 months wedge indicates low risk for the $224.16 million company. If the $7.83 price target is reached, the company will be worth $6.72M more.
Rising wedges, especially for downward breakouts are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 8% and 24%. The average rise is 28% and the decline is 14%. Wedges has high throwback and pullback rate: 73%, 63% and the percent of wedges meeting target is not more than 50%.

The stock decreased 0.57% or $0.0439 during the last trading session, reaching $7.6061. About 29,863 shares traded. Cytosorbents Corporation (NASDAQ:CTSO) has declined 4.26% since March 20, 2017 and is downtrending. It has underperformed by 20.96% the S&P500.

Analysts await Cytosorbents Corporation (NASDAQ:CTSO) to report earnings on May, 14. They expect $-0.07 earnings per share, down 40.00 % or $0.02 from last year’s $-0.05 per share. After $-0.12 actual earnings per share reported by Cytosorbents Corporation for the previous quarter, Wall Street now forecasts -41.67 % EPS growth.

Cytosorbents Corporation (NASDAQ:CTSO) Ratings Coverage

Among 7 analysts covering CytoSorbents (NASDAQ:CTSO), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CytoSorbents had 15 analyst reports since October 29, 2015 according to SRatingsIntel. Maxim Group maintained the shares of CTSO in report on Monday, July 17 with “Buy” rating. Cowen & Co maintained the shares of CTSO in report on Thursday, March 8 with “Buy” rating. Aegis Capital initiated the shares of CTSO in report on Wednesday, October 26 with “Buy” rating. H.C. Wainwright maintained it with “Buy” rating and $13.0 target in Tuesday, September 26 report. The firm has “Buy” rating by Maxim Group given on Tuesday, May 24. Maxim Group maintained Cytosorbents Corporation (NASDAQ:CTSO) rating on Tuesday, August 8. Maxim Group has “Buy” rating and $1200 target. On Tuesday, May 30 the stock rating was maintained by Aegis Capital with “Buy”. The stock has “Buy” rating by B. Riley & Co on Friday, October 7. As per Friday, March 9, the company rating was maintained by H.C. Wainwright. WBB Securities upgraded the shares of CTSO in report on Thursday, October 29 to “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.